Vector BioMed Expands LENTIVERSE™ Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access
PR Newswire —
The expansion of LENTIVERSE™ platform introduces "One Lentiviral Vector Platform, Two Paths to Advance Cures," aligning scientific rigor with transparent economics and global accessibility. GAITHERSBURG, Md., Nov. 6, 2025 /PRNewswire/ -- Vector BioMed, a leading lentiviral vector supplier...